$18.94
0.00% yesterday
NYSE, Oct 03, 10:03 pm CET
ISIN
US98888T1079
Symbol
ZIMV

ZimVie Stock price

$18.94
+0.08 0.42% 1M
+9.12 92.87% 6M
+4.99 35.77% YTD
+3.29 21.02% 1Y
+8.64 83.88% 3Y
-9.06 32.36% 5Y
-9.06 32.36% 10Y
-9.06 32.36% 20Y
NYSE, Closing price Fri, Oct 03 2025
+0.00 0.00%
ISIN
US98888T1079
Symbol
ZIMV

Key metrics

Basic
Market capitalization
$534.1m
Enterprise Value
$684.7m
Net debt
$150.6m
Cash
$70.2m
Shares outstanding
28.2m
Valuation (TTM | estimate)
P/E
negative | 20.4
P/S
1.2 | 1.2
EV/Sales
1.5 | 1.5
EV/FCF
121.8
P/B
1.3
Financial Health
Equity Ratio
50.7%
Return on Equity
-6.8%
ROCE
1.0%
ROIC
2.4%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$443.4m | $460.9m
EBITDA
$30.6m | $69.5m
EBIT
$6.3m | $41.0m
Net Income
$-19.5m | $26.2m
Free Cash Flow
$5.6m
Growth (TTM | estimate)
Revenue
-50.5% | 2.5%
EBITDA
-13.2% | 216.7%
EBIT
126.4% | 2,052.6%
Net Income
95.3% | 201.2%
Free Cash Flow
-77.4%
Margin (TTM | estimate)
Gross
65.3%
EBITDA
6.9% | 15.1%
EBIT
1.4%
Net
-4.4% | 5.7%
Free Cash Flow
1.3%
More
EPS
$-0.7
FCF per Share
$0.2
Short interest
1.6%
Employees
2k
Rev per Employee
$250.0k
Show more

Is ZimVie a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

ZimVie Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a ZimVie forecast:

6x Hold
67%
3x Sell
33%

Analyst Opinions

9 Analysts have issued a ZimVie forecast:

Hold
67%
Sell
33%

Financial data from ZimVie

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
443 443
50% 50%
100%
- Direct Costs 154 154
52% 52%
35%
290 290
50% 50%
65%
- Selling and Administrative Expenses 234 234
52% 52%
53%
- Research and Development Expense 25 25
52% 52%
6%
31 31
13% 13%
7%
- Depreciation and Amortization 24 24
59% 59%
5%
EBIT (Operating Income) EBIT 6.31 6.31
126% 126%
1%
Net Profit -19 -19
95% 95%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about ZimVie directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ZimVie Stock News

Neutral
Business Wire
18 days ago
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ZimVie Inc. (NasdaqGS: ZIMV) to an affiliate of ARCHIMED. Under the terms of the proposed transaction, shareholders of ZimVie will receive $19.00 in cash for each share of ZimVie that they own. KSF is s...
Neutral
GlobeNewsWire
about one month ago
NEW YORK, Aug. 23, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Neutral
The Motley Fool
2 months ago
ZimVie (ZIMV) Q2 EPS Doubles to $0.26
More ZimVie News

Company Profile

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and Dental Products segments. The Spine Products segment offers spinal surgery solutions such as implants, instrumentation, biologics, and bone healing technologies to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. The Dental Products segment provides dental implant solutions, biomaterial solutions, and digital dentistry. The company was founded on November 4, 2021 and is headquartered in Westminster, CO.

Head office United States
CEO Vafa Jamali
Employees 1,770
Founded 2021
Website www.zimvie.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today